Global Meningococcal Vaccines Market Insights and Forecast to 2026

Meningococcal Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Menactra

    Menomune

    Pneumonia

    Meningitis

    Bacteremia

    Others (Arthritis, Conjunctivitis, Urethritis)

Regional and Country-level Analysis

The Meningococcal Vaccines market is analysed and market size information is provided by regions (countries).

The key regions covered in the Meningococcal Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

Competitive Landscape and Meningococcal Vaccines Market Share Analysis

Meningococcal Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Meningococcal Vaccines business, the date to enter into the Meningococcal Vaccines market, Meningococcal Vaccines product introduction, recent developments, etc.

The major vendors covered:

    GlaxoSmithKline

    JN-International Medical

    Novartis International

    Sanofi

    Pfizer

    Baxter International

    ...

1.1 Meningococcal Vaccines Product Introduction

1.2 Market Segments

1.3 Key Meningococcal Vaccines Manufacturers Covered: Ranking by Revenue

1.4 Market by Type

1.4.1 Global Meningococcal Vaccines Market Size Growth Rate by Type

1.4.2 Menactra

1.4.3 Menomune

1.5 Market by Application

1.5.1 Global Meningococcal Vaccines Market Size Growth Rate by Application

1.5.2 Pneumonia

1.5.3 Meningitis

1.5.4 Bacteremia

1.5.5 Others (Arthritis, Conjunctivitis, Urethritis)

1.6 Study Objectives

1.7 Years Considered

2.1 Global Meningococcal Vaccines Market Size, Estimates and Forecasts

2.1.1 Global Meningococcal Vaccines Revenue 2015-2026

2.1.2 Global Meningococcal Vaccines Sales 2015-2026

2.2 Global Meningococcal Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026

2.2.1 Global Meningococcal Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020

2.2.2 Global Meningococcal Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3.1 Meningococcal Vaccines Sales by Manufacturers

3.1.1 Meningococcal Vaccines Sales by Manufacturers (2015-2020)

3.1.2 Meningococcal Vaccines Sales Market Share by Manufacturers (2015-2020)

3.2 Meningococcal Vaccines Revenue by Manufacturers

3.2.1 Meningococcal Vaccines Revenue by Manufacturers (2015-2020)

3.2.2 Meningococcal Vaccines Revenue Share by Manufacturers (2015-2020)

3.2.3 Global Meningococcal Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)

3.2.4 Global Top 10 and Top 5 Companies by Meningococcal Vaccines Revenue in 2019

3.2.5 Global Meningococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Meningococcal Vaccines Price by Manufacturers

3.4 Meningococcal Vaccines Manufacturing Base Distribution, Product Types

3.4.1 Meningococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Meningococcal Vaccines Product Type

3.4.3 Date of International Manufacturers Enter into Meningococcal Vaccines Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4.1 Global Meningococcal Vaccines Market Size by Type (2015-2020)

4.1.1 Global Meningococcal Vaccines Sales by Type (2015-2020)

4.1.2 Global Meningococcal Vaccines Revenue by Type (2015-2020)

4.1.3 Meningococcal Vaccines Average Selling Price (ASP) by Type (2015-2026)

4.2 Global Meningococcal Vaccines Market Size Forecast by Type (2021-2026)

4.2.1 Global Meningococcal Vaccines Sales Forecast by Type (2021-2026)

4.2.2 Global Meningococcal Vaccines Revenue Forecast by Type (2021-2026)

4.2.3 Meningococcal Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)

4.3 Global Meningococcal Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5.1 Global Meningococcal Vaccines Market Size by Application (2015-2020)

5.1.1 Global Meningococcal Vaccines Sales by Application (2015-2020)

5.1.2 Global Meningococcal Vaccines Revenue by Application (2015-2020)

5.1.3 Meningococcal Vaccines Price by Application (2015-2020)

5.2 Meningococcal Vaccines Market Size Forecast by Application (2021-2026)

5.2.1 Global Meningococcal Vaccines Sales Forecast by Application (2021-2026)

5.2.2 Global Meningococcal Vaccines Revenue Forecast by Application (2021-2026)

5.2.3 Global Meningococcal Vaccines Price Forecast by Application (2021-2026)

6.1 North America Meningococcal Vaccines by Country

6.1.1 North America Meningococcal Vaccines Sales by Country

6.1.2 North America Meningococcal Vaccines Revenue by Country

6.1.3 U.S.

6.1.4 Canada

6.2 North America Meningococcal Vaccines Market Facts & Figures by Type

6.3 North America Meningococcal Vaccines Market Facts & Figures by Application

7.1 Europe Meningococcal Vaccines by Country

7.1.1 Europe Meningococcal Vaccines Sales by Country

7.1.2 Europe Meningococcal Vaccines Revenue by Country

7.1.3 Germany

7.1.4 France

7.1.5 U.K.

7.1.6 Italy

7.1.7 Russia

7.2 Europe Meningococcal Vaccines Market Facts & Figures by Type

7.3 Europe Meningococcal Vaccines Market Facts & Figures by Application

8.1 Asia Pacific Meningococcal Vaccines by Region

8.1.1 Asia Pacific Meningococcal Vaccines Sales by Region

8.1.2 Asia Pacific Meningococcal Vaccines Revenue by Region

8.1.3 China

8.1.4 Japan

8.1.5 South Korea

8.1.6 India

8.1.7 Australia

8.1.8 Taiwan

8.1.9 Indonesia

8.1.10 Thailand

8.1.11 Malaysia

8.1.12 Philippines

8.1.13 Vietnam

8.2 Asia Pacific Meningococcal Vaccines Market Facts & Figures by Type

8.3 Asia Pacific Meningococcal Vaccines Market Facts & Figures by Application

9.1 Latin America Meningococcal Vaccines by Country

9.1.1 Latin America Meningococcal Vaccines Sales by Country

9.1.2 Latin America Meningococcal Vaccines Revenue by Country

9.1.3 Mexico

9.1.4 Brazil

9.1.5 Argentina

9.2 Central & South America Meningococcal Vaccines Market Facts & Figures by Type

9.3 Central & South America Meningococcal Vaccines Market Facts & Figures by Application

10.1 Middle East and Africa Meningococcal Vaccines by Country

10.1.1 Middle East and Africa Meningococcal Vaccines Sales by Country

10.1.2 Middle East and Africa Meningococcal Vaccines Revenue by Country

10.1.3 Turkey

10.1.4 Saudi Arabia

10.1.5 U.A.E

10.2 Middle East and Africa Meningococcal Vaccines Market Facts & Figures by Type

10.3 Middle East and Africa Meningococcal Vaccines Market Facts & Figures by Application

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Corporation Information

11.1.2 GlaxoSmithKline Description and Business Overview

11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)

11.1.4 GlaxoSmithKline Meningococcal Vaccines Products Offered

11.1.5 GlaxoSmithKline Related Developments

11.2 JN-International Medical

11.2.1 JN-International Medical Corporation Information

11.2.2 JN-International Medical Description and Business Overview

11.2.3 JN-International Medical Sales, Revenue and Gross Margin (2015-2020)

11.2.4 JN-International Medical Meningococcal Vaccines Products Offered

11.2.5 JN-International Medical Related Developments

11.3 Novartis International

11.3.1 Novartis International Corporation Information

11.3.2 Novartis International Description and Business Overview

11.3.3 Novartis International Sales, Revenue and Gross Margin (2015-2020)

11.3.4 Novartis International Meningococcal Vaccines Products Offered

11.3.5 Novartis International Related Developments

11.4 Sanofi

11.4.1 Sanofi Corporation Information

11.4.2 Sanofi Description and Business Overview

11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)

11.4.4 Sanofi Meningococcal Vaccines Products Offered

11.4.5 Sanofi Related Developments

11.5 Pfizer

11.5.1 Pfizer Corporation Information

11.5.2 Pfizer Description and Business Overview

11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)

11.5.4 Pfizer Meningococcal Vaccines Products Offered

11.5.5 Pfizer Related Developments

11.6 Baxter International

11.6.1 Baxter International Corporation Information

11.6.2 Baxter International Description and Business Overview

11.6.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)

11.6.4 Baxter International Meningococcal Vaccines Products Offered

11.6.5 Baxter International Related Developments

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Corporation Information

11.1.2 GlaxoSmithKline Description and Business Overview

11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)

11.1.4 GlaxoSmithKline Meningococcal Vaccines Products Offered

11.1.5 GlaxoSmithKline Related Developments

12.1 Meningococcal Vaccines Market Estimates and Projections by Region

12.1.1 Global Meningococcal Vaccines Sales Forecast by Regions 2021-2026

12.1.2 Global Meningococcal Vaccines Revenue Forecast by Regions 2021-2026

12.2 North America Meningococcal Vaccines Market Size Forecast (2021-2026)

12.2.1 North America: Meningococcal Vaccines Sales Forecast (2021-2026)

12.2.2 North America: Meningococcal Vaccines Revenue Forecast (2021-2026)

12.2.3 North America: Meningococcal Vaccines Market Size Forecast by Country (2021-2026)

12.3 Europe Meningococcal Vaccines Market Size Forecast (2021-2026)

12.3.1 Europe: Meningococcal Vaccines Sales Forecast (2021-2026)

12.3.2 Europe: Meningococcal Vaccines Revenue Forecast (2021-2026)

12.3.3 Europe: Meningococcal Vaccines Market Size Forecast by Country (2021-2026)

12.4 Asia Pacific Meningococcal Vaccines Market Size Forecast (2021-2026)

12.4.1 Asia Pacific: Meningococcal Vaccines Sales Forecast (2021-2026)

12.4.2 Asia Pacific: Meningococcal Vaccines Revenue Forecast (2021-2026)

12.4.3 Asia Pacific: Meningococcal Vaccines Market Size Forecast by Region (2021-2026)

12.5 Latin America Meningococcal Vaccines Market Size Forecast (2021-2026)

12.5.1 Latin America: Meningococcal Vaccines Sales Forecast (2021-2026)

12.5.2 Latin America: Meningococcal Vaccines Revenue Forecast (2021-2026)

12.5.3 Latin America: Meningococcal Vaccines Market Size Forecast by Country (2021-2026)

12.6 Middle East and Africa Meningococcal Vaccines Market Size Forecast (2021-2026)

12.6.1 Middle East and Africa: Meningococcal Vaccines Sales Forecast (2021-2026)

12.6.2 Middle East and Africa: Meningococcal Vaccines Revenue Forecast (2021-2026)

12.6.3 Middle East and Africa: Meningococcal Vaccines Market Size Forecast by Country (2021-2026)

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Porter's Five Forces Analysis

13.5 Primary Interviews with Key Meningococcal Vaccines Players (Opinion Leaders)

14.1 Value Chain Analysis

14.2 Meningococcal Vaccines Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables

    Table 1. Meningococcal Vaccines Market Segments

    Table 2. Ranking of Global Top Meningococcal Vaccines Manufacturers by Revenue (US$ Million) in 2019

    Table 3. Global Meningococcal Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

    Table 4. Major Manufacturers of Menactra

    Table 5. Major Manufacturers of Menomune

    Table 6. Global Meningococcal Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)

    Table 7. Global Meningococcal Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

    Table 8. Global Meningococcal Vaccines Sales by Regions 2015-2020 (K Units)

    Table 9. Global Meningococcal Vaccines Sales Market Share by Regions (2015-2020)

    Table 10. Global Meningococcal Vaccines Revenue by Regions 2015-2020 (US$ Million)

    Table 11. Global Meningococcal Vaccines Sales by Manufacturers (2015-2020) (K Units)

    Table 12. Global Meningococcal Vaccines Sales Share by Manufacturers (2015-2020)

    Table 13. Global Meningococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

    Table 14. Global Meningococcal Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccines as of 2019)

    Table 15. Meningococcal Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)

    Table 16. Meningococcal Vaccines Revenue Share by Manufacturers (2015-2020)

    Table 17. Key Manufacturers Meningococcal Vaccines Price (2015-2020) (USD/Unit)

    Table 18. Meningococcal Vaccines Manufacturers Manufacturing Base Distribution and Headquarters

    Table 19. Manufacturers Meningococcal Vaccines Product Type

    Table 20. Date of International Manufacturers Enter into Meningococcal Vaccines Market

    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 22. Global Meningococcal Vaccines Sales by Type (2015-2020) (K Units)

    Table 23. Global Meningococcal Vaccines Sales Share by Type (2015-2020)

    Table 24. Global Meningococcal Vaccines Revenue by Type (2015-2020) (US$ Million)

    Table 25. Global Meningococcal Vaccines Revenue Share by Type (2015-2020)

    Table 26. Meningococcal Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)

    Table 27. Global Meningococcal Vaccines Sales by Application (2015-2020) (K Units)

    Table 28. Global Meningococcal Vaccines Sales Share by Application (2015-2020)

    Table 29. North America Meningococcal Vaccines Sales by Country (2015-2020) (K Units)

    Table 30. North America Meningococcal Vaccines Sales Market Share by Country (2015-2020)

    Table 31. North America Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)

    Table 32. North America Meningococcal Vaccines Revenue Market Share by Country (2015-2020)

    Table 33. North America Meningococcal Vaccines Sales by Type (2015-2020) (K Units)

    Table 34. North America Meningococcal Vaccines Sales Market Share by Type (2015-2020)

    Table 35. North America Meningococcal Vaccines Sales by Application (2015-2020) (K Units)

    Table 36. North America Meningococcal Vaccines Sales Market Share by Application (2015-2020)

    Table 37. Europe Meningococcal Vaccines Sales by Country (2015-2020) (K Units)

    Table 38. Europe Meningococcal Vaccines Sales Market Share by Country (2015-2020)

    Table 39. Europe Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)

    Table 40. Europe Meningococcal Vaccines Revenue Market Share by Country (2015-2020)

    Table 41. Europe Meningococcal Vaccines Sales by Type (2015-2020) (K Units)

    Table 42. Europe Meningococcal Vaccines Sales Market Share by Type (2015-2020)

    Table 43. Europe Meningococcal Vaccines Sales by Application (2015-2020) (K Units)

    Table 44. Europe Meningococcal Vaccines Sales Market Share by Application (2015-2020)

    Table 45. Asia Pacific Meningococcal Vaccines Sales by Region (2015-2020) (K Units)

    Table 46. Asia Pacific Meningococcal Vaccines Sales Market Share by Region (2015-2020)

    Table 47. Asia Pacific Meningococcal Vaccines Revenue by Region (2015-2020) (US$ Million)

    Table 48. Asia Pacific Meningococcal Vaccines Revenue Market Share by Region (2015-2020)

    Table 49. Asia Pacific Meningococcal Vaccines Sales by Type (2015-2020) (K Units)

    Table 50. Asia Pacific Meningococcal Vaccines Sales Market Share by Type (2015-2020)

    Table 51. Asia Pacific Meningococcal Vaccines Sales by Application (2015-2020) (K Units)

    Table 52. Asia Pacific Meningococcal Vaccines Sales Market Share by Application (2015-2020)

    Table 53. Latin America Meningococcal Vaccines Sales by Country (2015-2020) (K Units)

    Table 54. Latin America Meningococcal Vaccines Sales Market Share by Country (2015-2020)

    Table 55. Latin Americaa Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)

    Table 56. Latin America Meningococcal Vaccines Revenue Market Share by Country (2015-2020)

    Table 57. Latin America Meningococcal Vaccines Sales by Type (2015-2020) (K Units)

    Table 58. Latin America Meningococcal Vaccines Sales Market Share by Type (2015-2020)

    Table 59. Latin America Meningococcal Vaccines Sales by Application (2015-2020) (K Units)

    Table 60. Latin America Meningococcal Vaccines Sales Market Share by Application (2015-2020)

    Table 61. Middle East and Africa Meningococcal Vaccines Sales by Country (2015-2020) (K Units)

    Table 62. Middle East and Africa Meningococcal Vaccines Sales Market Share by Country (2015-2020)

    Table 63. Middle East and Africa Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)

    Table 64. Middle East and Africa Meningococcal Vaccines Revenue Market Share by Country (2015-2020)

    Table 65. Middle East and Africa Meningococcal Vaccines Sales by Type (2015-2020) (K Units)

    Table 66. Middle East and Africa Meningococcal Vaccines Sales Market Share by Type (2015-2020)

    Table 67. Middle East and Africa Meningococcal Vaccines Sales by Application (2015-2020) (K Units)

    Table 68. Middle East and Africa Meningococcal Vaccines Sales Market Share by Application (2015-2020)

    Table 69. GlaxoSmithKline Corporation Information

    Table 70. GlaxoSmithKline Description and Major Businesses

    Table 71. GlaxoSmithKline Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 72. GlaxoSmithKline Product

    Table 73. GlaxoSmithKline Recent Development

    Table 74. JN-International Medical Corporation Information

    Table 75. JN-International Medical Description and Major Businesses

    Table 76. JN-International Medical Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 77. JN-International Medical Product

    Table 78. JN-International Medical Recent Development

    Table 79. Novartis International Corporation Information

    Table 80. Novartis International Description and Major Businesses

    Table 81. Novartis International Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 82. Novartis International Product

    Table 83. Novartis International Recent Development

    Table 84. Sanofi Corporation Information

    Table 85. Sanofi Description and Major Businesses

    Table 86. Sanofi Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 87. Sanofi Product

    Table 88. Sanofi Recent Development

    Table 89. Pfizer Corporation Information

    Table 90. Pfizer Description and Major Businesses

    Table 91. Pfizer Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 92. Pfizer Product

    Table 93. Pfizer Recent Development

    Table 94. Baxter International Corporation Information

    Table 95. Baxter International Description and Major Businesses

    Table 96. Baxter International Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 97. Baxter International Product

    Table 98. Baxter International Recent Development

    Table 99. Global Meningococcal Vaccines Sales Forecast by Regions (2021-2026) (K Units)

    Table 100. Global Meningococcal Vaccines Sales Market Share Forecast by Regions (2021-2026)

    Table 101. Global Meningococcal Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)

    Table 102. Global Meningococcal Vaccines Revenue Market Share Forecast by Regions (2021-2026)

    Table 103. North America: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)

    Table 104. North America: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 105. Europe: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)

    Table 106. Europe: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 107. Asia Pacific: Meningococcal Vaccines Sales Forecast by Region (2021-2026) (K Units)

    Table 108. Asia Pacific: Meningococcal Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)

    Table 109. Latin America: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)

    Table 110. Latin America: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 111. Middle East and Africa: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)

    Table 112. Middle East and Africa: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)

    Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)

    Table 114. Key Challenges

    Table 115. Market Risks

    Table 116. Main Points Interviewed from Key Meningococcal Vaccines Players

    Table 117. Meningococcal Vaccines Customers List

    Table 118. Meningococcal Vaccines Distributors List

    Table 119. Research Programs/Design for This Report

    Table 120. Key Data Information from Secondary Sources

    Table 121. Key Data Information from Primary Sources

List of Figures

    Figure 1. Meningococcal Vaccines Product Picture

    Figure 2. Global Meningococcal Vaccines Sales Market Share by Type in 2020 & 2026

    Figure 3. Menactra Product Picture

    Figure 4. Menomune Product Picture

    Figure 5. Global Meningococcal Vaccines Sales Market Share by Application in 2020 & 2026

    Figure 6. Pneumonia

    Figure 7. Meningitis

    Figure 8. Bacteremia

    Figure 9. Others (Arthritis, Conjunctivitis, Urethritis)

    Figure 10. Meningococcal Vaccines Report Years Considered

    Figure 11. Global Meningococcal Vaccines Market Size 2015-2026 (US$ Million)

    Figure 12. Global Meningococcal Vaccines Sales 2015-2026 (K Units)

    Figure 13. Global Meningococcal Vaccines Market Size Market Share by Region: 2020 Versus 2026

    Figure 14. Global Meningococcal Vaccines Sales Market Share by Region (2015-2020)

    Figure 15. Global Meningococcal Vaccines Sales Market Share by Region in 2019

    Figure 16. Global Meningococcal Vaccines Revenue Market Share by Region (2015-2020)

    Figure 17. Global Meningococcal Vaccines Revenue Market Share by Region in 2019

    Figure 18. Global Meningococcal Vaccines Sales Share by Manufacturer in 2019

    Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Vaccines Revenue in 2019

    Figure 20. Meningococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

    Figure 21. Global Meningococcal Vaccines Sales Market Share by Type (2015-2020)

    Figure 22. Global Meningococcal Vaccines Sales Market Share by Type in 2019

    Figure 23. Global Meningococcal Vaccines Revenue Market Share by Type (2015-2020)

    Figure 24. Global Meningococcal Vaccines Revenue Market Share by Type in 2019

    Figure 25. Global Meningococcal Vaccines Market Share by Price Range (2015-2020)

    Figure 26. Global Meningococcal Vaccines Sales Market Share by Application (2015-2020)

    Figure 27. Global Meningococcal Vaccines Sales Market Share by Application in 2019

    Figure 28. Global Meningococcal Vaccines Revenue Market Share by Application (2015-2020)

    Figure 29. Global Meningococcal Vaccines Revenue Market Share by Application in 2019

    Figure 30. North America Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)

    Figure 31. North America Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 32. North America Meningococcal Vaccines Sales Market Share by Country in 2019

    Figure 33. North America Meningococcal Vaccines Revenue Market Share by Country in 2019

    Figure 34. U.S. Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 35. U.S. Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 36. Canada Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 37. Canada Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 38. North America Meningococcal Vaccines Market Share by Type in 2019

    Figure 39. North America Meningococcal Vaccines Market Share by Application in 2019

    Figure 40. Europe Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)

    Figure 41. Europe Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 42. Europe Meningococcal Vaccines Sales Market Share by Country in 2019

    Figure 43. Europe Meningococcal Vaccines Revenue Market Share by Country in 2019

    Figure 44. Germany Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 45. Germany Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 46. France Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 47. France Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 48. U.K. Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 49. U.K. Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 50. Italy Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 51. Italy Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 52. Russia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 53. Russia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 54. Europe Meningococcal Vaccines Market Share by Type in 2019

    Figure 55. Europe Meningococcal Vaccines Market Share by Application in 2019

    Figure 56. Asia Pacific Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)

    Figure 57. Asia Pacific Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 58. Asia Pacific Meningococcal Vaccines Sales Market Share by Region in 2019

    Figure 59. Asia Pacific Meningococcal Vaccines Revenue Market Share by Region in 2019

    Figure 60. China Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 61. China Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 62. Japan Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 63. Japan Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 64. South Korea Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 65. South Korea Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 66. India Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 67. India Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 68. Australia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 69. Australia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 70. Taiwan Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 71. Taiwan Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 72. Indonesia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 73. Indonesia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 74. Thailand Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 75. Thailand Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 76. Malaysia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 77. Malaysia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 78. Philippines Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 79. Philippines Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 80. Vietnam Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 81. Vietnam Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 82. Asia Pacific Meningococcal Vaccines Market Share by Type in 2019

    Figure 83. Asia Pacific Meningococcal Vaccines Market Share by Application in 2019

    Figure 84. Latin America Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)

    Figure 85. Latin America Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 86. Latin America Meningococcal Vaccines Sales Market Share by Country in 2019

    Figure 87. Latin America Meningococcal Vaccines Revenue Market Share by Country in 2019

    Figure 88. Mexico Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 89. Mexico Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 90. Brazil Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 91. Brazil Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 92. Argentina Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 93. Argentina Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 94. Latin America Meningococcal Vaccines Market Share by Type in 2019

    Figure 95. Latin America Meningococcal Vaccines Market Share by Application in 2019

    Figure 96. Middle East and Africa Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)

    Figure 97. Middle East and Africa Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)

    Figure 98. Middle East and Africa Meningococcal Vaccines Sales Market Share by Country in 2019

    Figure 99. Middle East and Africa Meningococcal Vaccines Revenue Market Share by Country in 2019

    Figure 100. Turkey Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 101. Turkey Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 102. Saudi Arabia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 103. Saudi Arabia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 104. U.A.E Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)

    Figure 105. U.A.E Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 106. Middle East and Africa Meningococcal Vaccines Market Share by Type in 2019

    Figure 107. Middle East and Africa Meningococcal Vaccines Market Share by Application in 2019

    Figure 108. North America Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)

    Figure 109. North America Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 110. Europe Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)

    Figure 111. Europe Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 112. Asia Pacific Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)

    Figure 113. Asia Pacific Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 114. Latin America Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)

    Figure 115. Latin America Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 116. Middle East and Africa Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)

    Figure 117. Middle East and Africa Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)

    Figure 118. Porter's Five Forces Analysis

    Figure 119. Channels of Distribution

    Figure 120. Distributors Profiles

    Figure 121. Bottom-up and Top-down Approaches for This Report

    Figure 122. Data Triangulation

    Figure 123. Key Executives Interviewed